​

Funding Round

Series B - Crescendo Bioscience

Series B - Crescendo Bioscience

Investment Firm

Overview

Crescendo Bioscience develops diagnostic tools to provide rheumatologists with clinical insights to autoimmune and inflammatory disease.

Announced Date

Jun 27, 2008

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Mohr Davidow Ventures

Mohr Davidow Ventures

Mohr Davidow Ventures is a debt and early_stage_venture and late_stage_venture firm.

Kleiner Perkins

Kleiner Perkins

Kleiner Perkins is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorKleiner Perkins
Participant InvestorMohr Davidow Ventures

Round Details and Background

Crescendo Bioscience raised $15000000 on 2008-06-27 in Series B

Crescendo Bioscience develops diagnostic tools to provide rheumatologists with clinical insights to autoimmune and inflammatory disease.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 20, 2011
Debt Financing - Crescendo Bioscience
1-25.0M
Jan 03, 2013
Series D - Crescendo Bioscience
5-28.0M
Sep 08, 2011
Series C - Crescendo Bioscience
4-31.0M
Jul 07, 2010
Series B - Crescendo Bioscience
2-37.6M

Recent Activity

There is no recent news or activity for this profile.